Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt

Autor: Cecilia Marini 1, 2, Silvia Ravera 3, Ambra Buschiazzo 2, Giovanna Bianchi 4, Anna Maria Orengo 2, Silvia Bruno 5, Gianluca Bottoni 2, Laura Emionite 6, Fabio Pastorino 4, Elena Monteverde 2, Lucia Garaboldi 2, Roberto Martella 4, Barbara Salani 7, Davide Maggi 7, Mirco Ponzoni 4, Franco Fais 5, 8, Lizzia Raffaghello 4, Gianmario Sambuceti 2

Publikováno v: Scientific Reports
Scientific reports (Nature Publishing Group) 6 (2016): 25092. doi:10.1038/srep25092
info:cnr-pdr/source/autori:Cecilia Marini 1,2,*, Silvia Ravera 3,*, Ambra Buschiazzo 2, Giovanna Bianchi 4, Anna Maria Orengo 2, Silvia Bruno 5, Gianluca Bottoni 2, Laura Emionite 6, Fabio Pastorino 4, Elena Monteverde 2, Lucia Garaboldi 2, Roberto Martella 4, Barbara Salani 7, Davide Maggi 7, Mirco Ponzoni 4, Franco Fais 5,8, Lizzia Raffaghello 4 & Gianmario Sambuceti 2/titolo:Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt./doi:10.1038%2Fsrep25092/rivista:Scientific reports (Nature Publishing Group)/anno:2016/pagina_da:/pagina_a:25092/intervallo_pagine:25092/volume:6

Cancer metabolism is characterized by an accelerated glycolytic rate facing reduced activity of oxidative phosphorylation. This “Warburg effect” represents a standard to diagnose and monitor tumor aggressiveness with 18F-fluorodeoxyglucose whose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d51310109f7bb11e9665c5fa9824f1
https://pubmed.ncbi.nlm.nih.gov/27121192